Literature DB >> 2778132

Dilated Virchow-Robin spaces in cryptococcal meningitis associated with AIDS: CT and MR findings.

S M Wehn1, E R Heinz, P C Burger, O B Boyko.   

Abstract

We present two patients with AIDS complicated by cryptococcal meningitis who displayed focal hypodense nonenhancing lesions in CT in the basal ganglia with corresponding areas of increased T2 and decreased T1 signal on magnetic resonance (MR). These lesions corresponded precisely to the distribution of the perforating arteries. Review of pathological specimens showed these lesions to be small cystic collections of cryptococcal organisms in the perivascular spaces of the arteries with minimal or no inflammatory reaction. The cryptococcal organisms spread from the basal cisterns through the Virchow-Robin spaces, dilating these spaces, to ultimately propagate in the basal ganglia, internal capsule, thalamus, and brain stem. Such lesions have been described as characteristic for cryptococcosis in the pathology literature before the AIDS epidemic, but the radiological manifestations have not been reported previously. The changes appear characteristic for cryptococcosis, which generally incites no host response in the form of perifocal edema or enhancement. These findings in a young adult, with otherwise normal CT or MR scans, may be the first indication that the patient has AIDS. The T2-weighted image sequences are more sensitive in the detection of these lesions when compared to CT or T1-weighted MR images.

Entities:  

Mesh:

Year:  1989        PMID: 2778132     DOI: 10.1097/00004728-198909000-00002

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  18 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

Review 2.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

3.  Gd-DTPA-enhanced MR imaging of cryptococcal meningoencephalitis.

Authors:  A Takasu; M Taneda; H Otuki; Y Okamoto; K Oku
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

4.  Assessing the chronic neuropsychologic sequelae of human immunodeficiency virus-negative cryptococcal meningitis by using diffusion tensor imaging.

Authors:  C-H Lu; H-L Chen; W-N Chang; N-W Tsai; H-C Wang; T-M Yang; Y-J Lin; C-P Lin; C-C Chen; B-C Cheng; W-C Lin
Journal:  AJNR Am J Neuroradiol       Date:  2011-05-19       Impact factor: 3.825

5.  Cryptococcal choroid plexitis as a mass lesion: MR imaging and histopathologic correlation.

Authors:  Jerry M E Kovoor; Anita Mahadevan; Jayakumar P Narayan; Srikanth S Govindappa; P Satishchandra; Anisya V Taly; S K Shankar
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

6.  Nipah viral encephalitis or Japanese encephalitis? MR findings in a new zoonotic disease.

Authors:  C C Lim; Y Y Sitoh; F Hui; K E Lee; B S Ang; E Lim; W E Lim; H M Oh; P A Tambyah; J S Wong; C B Tan; T S Chee
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

7.  Pathological findings correlated with MRI in HIV infection.

Authors:  C P Hawkins; J E McLaughlin; B E Kendall; W I McDonald
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

8.  MRI of a pituitary cryptococcoma simulating an adenoma.

Authors:  Y Q Yu; X X Jiang; Y J Gao
Journal:  Neuroradiology       Date:  1995-08       Impact factor: 2.804

9.  High signal intensity of both putamina in patients with HIV infection.

Authors:  T Kodama; Y Numaguchi; F E Gellad; N Sadato
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

10.  Mycotic encephalitis: predilection for grey matter.

Authors:  M S van der Knaap; J Valk; G H Jansen; L J Kappelle; O van Nieuwenhuizen
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.